[struggle]

“Please don’t take this $1 a pill, generic protease inhibitor. We’re about to develop a $2,000 a pill protease inhibitor.”

[mewzilla]

Merckmectin!

[gcparent]

Sure scare the heck out if everyone then charge like they do forVictoza.

[StAnDeliver]

"We’re about to develop a $2,000 a pill protease inhibitor."

Actually, $1,700-per-dosage Molnupiravir, an RNA chain-terminator, which works by spoofing an amino acid in the COVID virus self-repair machine. Unlike Remdesivir, it can be given orally.

Ridgeback partnered with Merck last summer to develop Molnupiravir for oral delivery to COVID patients.

In June of this year, Merck received FDA's 1.2B public committment for 1.7 million doses, with prospectus for 10 million total doses in the future.